Gianluca Imeri

Gianluca Imeri

Auto-generated profile, based on publicly available information

Gianluca Imeri

Respiratory Unit, ASST Papa Giovanni XXIII

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in European Journal of Radiology
Verified
Journal Article
Closed access
MBMaurizio Balbi
Maurizio Balbi
CCCaterina Conti
Caterina Conti
GIGianluca Imeri
Gianluca Imeri
ACAnna Caroli
Anna Caroli
ASAlessandra Surace
Alessandra Surace
SSSandro Sironi
Sandro Sironi

13 October 2022 in Tomography
Verified
Journal Article
Open access
PDF file
ACAndrea Corsi
Andrea Corsi
ACAnna Caroli
Anna Caroli
Pietro Andrea BonaffiniPietro Andrea Bonaffini
Pietro Andrea Bonaffini
CCCaterina Conti
Caterina Conti
AAAlberto Arrigoni
Alberto Arrigoni
SSSandro Sironi
Sandro Sironi
Long-term pulmonary sequelae in COVID-19 patients are currently under investigation worldwide. Potential relationships between blood sampling and functional and radiological findings are crucial to guide the follow-up. In this study, we collected and evaluated clinical status, namely symptoms and patients’ reported outcome, pulmonary function tests (PFT), laboratory tests, and radiological findings at 3- and 12-months post-discharge in patients admitted between 25 February and 2 May 2020, and who survived severe COVID-19 pneumonia. A history of chronic pulmonary disease or COVID-19-unrelated complications were used as exclusion criteria. Unenhanced CTs were analyzed quantitatively (compromising lung volume %) and qualitatively, with main patterns of: ground-glass opacity (GGO), consolidation, and reticular configuration. Patients were subsequently divided into groups based on their radiological trends and according to the evolution in the percentage of compromised lung volume. At 12 months post-discharge, seventy-one patients showed significantly improved laboratory tests and PFT. Among them, 63 patients also underwent CT examination: all patients with negative CT findings at three months (n = 14) had negative CT also at 12 months; among the 49/63 patients presenting CT alterations at three months, 1/49 (2%) normalized, 40/49 (82%) improved, 7/49 (14%) remained stably abnormal, and 1/49 (2%) worsened. D-dimer values were low in patients with normal CT and higher in cases with improved or stably abnormal CT (median values 213 vs. 329 vs. 1000 ng/mL, respectively). The overall compromised lung volume was reduced compared with three months post-discharge (12.3 vs. 14.4%, p < 0.001). In stably abnormal CT, the main pulmonary pattern changed, showing a reduction in GGO and an increase in reticular configuration. To summarize, PFT are normal in most COVID-19 survivors 12 months post-discharge, but CT structural abnormalities persist (although sensibly improved over time) and are associated with higher D-dimer values.

6 March 2024 in Multidisciplinary Respiratory Medicine
Verified
Journal Article
Open access
PDF file
GIGianluca Imeri
Gianluca Imeri
CCCaterina Conti
Caterina Conti
ACAnna Caroli
Anna Caroli
AAAlberto Arrigoni
Alberto Arrigoni
Pietro Andrea BonaffiniPietro Andrea Bonaffini
Pietro Andrea Bonaffini
FMFabiano Di Marco
Fabiano Di Marco
Background: There are uncertainties whether the impairment of lung diffusing capacity in COVID-19 is due to an alteration in the diffusive conductance of the alveolar membrane (Dm), or an alteration of the alveolar capillary volume (Vc), or a combination of both. The combined measurement DLNO and DLCO diffusion, owing to NO higher affinity and faster reaction rate with haemoglobin compared to CO, enables the simultaneous and rapid determination of both Vc and Dm. The aim of the present study was to better identify the precise cause of post-COVID-19 diffusion impairment.Methods: Using the combined NO and CO gas transfer techniques (DLNO and DLCO), it is possible to better understand whether gas exchange abnormalities are due to membrane or alveolar capillary volume components. The present study was aimed at evaluating pulmonary gas exchange one year after severe COVID-19. Results: The cohort included 33 survivors to severe COVID-19 (median age 67 years, 70% male) with no pre-existing lung disease, who underwent clinical, lung function and imaging assessments at 12 months due to persistence of respiratory symptoms or radiological impairment. The gas exchange abnormalities were mainly determined by the compromise of the vascular component as demonstrated by vascular pattern of gas exchange impairment (i.e., DLNO/DLCO≥110%, 76% of the sample), and by a reduction of the Vc (73%), while the Dm was reduced only in 9% of the entire sample. We did not find a correlation between the gas exchange impairment and the extent of the chest CT alterations (DLCO p = 0.059 and DLNO p = 0.054), which on average were found to be mild (11% of the parenchyma).Conclusion: In COVID-19 survivors who are still symptomatic or have minimal CT findings at one year, gas exchange abnormalities are determined by impairment of the vascular component, rather than the diffusive component of the alveolar membrane.

25 August 2025 in BMJ Open Respiratory Research
Verified
Journal Article
Open access
PDF file
GZGerald Stanley Zavorsky
Gerald Stanley Zavorsky
GBGiovanni Barisione
Giovanni Barisione
TGThomas Gille
Thomas Gille
RNRoberto W. Dal Negro
Roberto W. Dal Negro
MNMarta Nuñez-Fernandez
Marta Nuñez-Fernandez
VBVito Brusasco
Vito Brusasco
Background: Persistent pulmonary dysfunction is common after COVID-19, yet traditional assessments using carbon monoxide diffusing capacity (DLCO) alone may miss alveolar-capillary impairment. Objective: To determine whether combining nitric oxide (DLNO 5s ) and carbon monoxide (DLCO 5s ) diffusing capacities enhances detection of post-COVID-19 lung impairment and whether summed z -scores outperform individual measures in classifying affected individuals. Design and methods: We conducted an individual participant data meta-analysis using hierarchical mixed-effects modelling. The dataset included 572 COVID-19 survivors and 72 matched controls from six European centres. Lung function metrics—including spirometry, total lung capacity, DLNO 5s and DLCO 5s —were standardised into z -scores. Logistic models were compared using Bayesian Information Criterion and Leave-One-Out Information Criterion. Classification accuracy was assessed with Matthews Correlation Coefficient (MCC) and net reclassification improvement (NRI). Principal Component Analysis examined score structures, and dyspnoea severity was correlated with z-scores. Assessments were conducted 32–575 days post-infection (median=130 days). Results: The number of days between SARS-CoV-2 diagnosis and testing did not affect any of the measured z‐scores. Summed DLNO 5s + DLCO 5s z -scores consistently outperformed individual metrics. The combined model improved MCC by 0.06 (95% CI 0.01 to 0.11) and NRI by 37% (95% CI 13 to 62%) over DLCO 5s alone. The top model (summed DLNO 5s + DLCO 5s z-scores model) explained 10% of fixed and 59% of random variance. DLCO 5s alone failed to identify reduced membrane diffusion in approximately 16% of cases. Dyspnoea severity was significantly associated with all diffusion indices (p<0.001), though combined scores showed no stronger correlation than single predictors. Conclusion: Summed DLNO 5s + DLCO 5s z -scores enhance classification of post-COVID-19 pulmonary impairment beyond DLCO 5s alone. The NO-CO double diffusion approach offers improved diagnostic discrimination between previously infected individuals and controls and aligns with symptom severity. These findings support broader clinical integration of combined diffusion metrics in post-COVID assessment.

25 July 2025 in Data in Brief
Verified
Journal Article
Open access
GZGerald Stanley Zavorsky
Gerald Stanley Zavorsky
GBGiovanni Barisione
Giovanni Barisione
TGThomas Gille
Thomas Gille
RNRoberto W. Dal Negro
Roberto W. Dal Negro
MNMarta Nuñez-Fernandez
Marta Nuñez-Fernandez
VBVito Brusasco
Vito Brusasco
Pulmonary complications remain a significant challenge for COVID-19 survivors, necessitating advanced diagnostic approaches for long-term assessment. We present a curated, open-access dataset of pulmonary function measurements—including nitric oxide (DLNO) and carbon monoxide (DLCO) diffusing capacities—in 572 post–COVID-19 patients and 72 healthy controls (filtered from an original cohort of 726 survivors and 126 controls). Collected across eight international centres, the data include demographics, spirometry, lung volumes, and 5–6 s single-breath DLNO5s, DLCO5s, and alveolar volume (VA5s). Missing values for total lung capacity were imputed, and low-quality or system-specific (Hyp’Air Compact) measurements were excluded in the filtered dataset. A third subset (333 patients, 54 controls) links these measurements to dyspnoea severity (mMRC scale) for correlation and proportional odds analyses. This resource underpins predictive modeling of post–COVID pulmonary impairment via summed z-scores (DLNO + DLCO) and aims to accelerate validation of NO-CO diagnostics. The freely accessible datasets are provided in both SPSS (.sav) and .csv formats at the Mendeley Data Cloud-based repository and includes nominal, ordinal, and scalar data.

17 June 2026 in Annals of Medicine
Verified
Journal Article
Open access
AAAlberto Arrigoni
Alberto Arrigoni
SCSerena Capelli
Serena Capelli
GIGianluca Imeri
Gianluca Imeri
FPFRANCESCA PENNATI
FRANCESCA PENNATI
SVSerena Venturelli
Serena Venturelli
ACAnna Caroli
Anna Caroli
COVID-19 primarily affects the respiratory system, with pulmonary function tests (PFTs) evaluating respiratory impairments and chest CT imaging revealing structural lung abnormalities. However, the disease’s multisystem impact – including vascular dysfunction and neurological complications associated with MRI neuroimaging alterations – raises the possibility of shared mechanisms underlying both pulmonary and cerebral involvement, potentially mediated by vascular damage. The study included 27 consecutive COVID-19 patients (median age 59.0 [IQR 50.5 – 70.0] years, 37% female) presenting with concurrent respiratory and neurological symptoms. All patients underwent PFTs, chest CT, and brain MRI. CT images were processed to quantify lung parenchyma, airways, and vasculature, including small-vessel volume (SVV) and air-to-perfusion ratio (APR). Brain MRI analysis assessed gray matter (GM) integrity (volume and cortical thickness), white matter (WM) diffusion metrics (Apparent Diffusion Coefficient, ADC), and GM perfusion (cerebral blood volume, CBV; cerebral blood flow, CBF). Relationships between pulmonary and cerebral metrics were explored using Spearman correlations and multivariable linear regression. GM volume was positively associated with diffusing capacity for carbon monoxide (DLCO), and cortical thickness was positively associated with alveolar volume (VA). No associations were observed for WM ADC. In contrast, lower pulmonary function (DLCO, VA, forced expiratory volume in 1 s (FEV1), and forced vital capacity (FVC)) were associated with higher GM perfusion. COVID-19-related pulmonary impairment is associated with reduced GM structural integrity and altered cerebral perfusion, suggesting a lung-brain interplay potentially driven by systemic vascular dysfunction and adaptive cerebrovascular mechanisms. These findings underscore the importance of integrated pulmonary and neurological assessment in post-COVID-19 patients and highlight the need for longitudinal studies to clarify the evolution and clinical consequences of these alterations.